Reporting Transparency and Completeness in Trials: Paper 1: Introduction - Better reporting for disruptive clinical trials using routinely collected data

In 2013, Lauer and D'Agostino wrote that “the randomized registry trial represents a disruptive technology, a technology that transforms existing standards, procedures, and cost structures" [1]. Indeed, numerous examples since then have shown that randomized clinical trials using routinely collected data (RCD-RCTs) or data from cohorts c an provide insights that were previously possible only at great expense, if at all [2,3]. Routinely collected data (RCD; e.g., from registries, electronic health records, or administrative databases) are data that are typically collected for purposes other than research via established data infrastr uctures [4].
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Tags: Editorial Source Type: research